Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GenSci134
- Development stage
- Phase 2
- Lead developer
- Changchun GeneScience Pharmaceutical
- Administration
- Subcutaneous
01
Overview
GenSci134 is a **subcutaneously administered biological growth hormone** developed for the treatment of **growth hormone deficiency** and potentially other undisclosed endocrine or metabolic disorders. The product is classified as a **class 1 therapeutic biologic** and is being developed by **Changchun Genescience Pharmaceuticals**. Its mechanism of action likely involves stimulating growth and metabolic effects characteristic of growth hormone therapies, although specific molecular or cellular targets have not been disclosed. As of mid-2025, GenSci134 is in early phase clinical development, specifically a Phase 1 dose-escalation study in healthy adult males to evaluate safety and tolerability[1][3][5][7].
- Brand names
- GenSci134GenSci-134GenSci 134
- Other names
- GenSci134GenSci-134GenSci 134
02
Targets
GHR (Growth hormone receptor)
Beyond the preview
Go deeper on GenSci134.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenSci134.